Guidance for Laboratory Biomonitoring Programs: Developing Biomonitoring Capabilities

Details

• Alternative Title:
  Guidance for biomonitoring programs
• Corporate Authors:
  Association of Public Health Laboratories (U.S.) ; Centers for Disease Control and Prevention (U.S.O
• Description:
  The goals of this guidance are to outline the infrastructure and expertise needed to develop laboratory capacity for a biomonitoring program and to highlight some of the main considerations chemists should address before beginning a biomonitoring study, which include the need to: ; • Define the goals of a biomonitoring study; ; • Choose the appropriate biomarker in the appropriate matrix at a suf cient level of sensitivity; ; • Identify resource needs and sources of potential funding; ; • Collaborate with epidemiologists and toxicologists in the development of the study design and to analyze and communicate biomonitoring data; ; • Produce reliable, valid and comparable data; ; • Engage the community early in the study design process; and ; • Develop an effective communication plan that involves reporting of individual results (if appropriate), aggregate data and access to public health, citizens or medical professionals for results distribution and interpretation. ; While the technology and instrumentation used for biomonitoring testing have a lot in common with environmental testing laboratories, biomonitoring presents a set of unique challenges. Assaying clinical matrices involves the safe handling of potentially infectious materials, different interferences, and possibly the analysis of metabolites. The greatest differences between bio- monitoring and environmental testing involve the interpretation of clinical ndings and effective communication of results on an individual and community basis. ; EH_2012_Guidance-for-Laboratory-Biomonitoring-Programs.pdf ; Running title: Guidance for biomonitoring programs. ; This report was supported 100% by Cooperative Agreement Number #U60/CD303019 from Centers for Disease Con- trol and Prevention (“CDC”). Its contents are solely the responsibility of the authors and do not necessarily represent the of cial views of CDC.
  More +
• Subjects:
  • Environmental Health
  • Environmental Monitoring
  • Laboratories
  • Sample Size
  • Specimen Handling
• Series:
  Association of Public Health Laboratories (APHL) Report
• Document Type:
  Text
• Funding:
  CDC cooperative agreement number #U60/CD303019
• Genre:
  Pamphlet (or booklet)
• Pages in Document:
  79 numbered pages
• Download URL:
  https://stacks.cdc.gov/view/cdc/53202/cdc_53202_DS1.pdf
• File Type:
  [PDF - 932.79 KB]
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:1bd89f030d4158816b0c11c24593b512252d8a0573008fd07429260fb3d501bc825b0c2ea17c45446d3ce3127dd149436b246dbef8fa9fe651ad72789e99a13c